Ticker
  • Companies
  • RNS
  • AI Chat
  • Research
  • Indices
  • Ticker TV
  • Events
  • Commodities
  • Currencies
Ticker
⌘K
Developer PortalNewsServices
/Equities/AIMX/COG
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Cambridge Cognition Holdings PLC logo
Cambridge Cognition Holdings PLC
/Equities/AIMX/COG
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Cambridge Cognition Holdings PLC logo

Cambridge Cognition Holdings PLC

Loading price data...
--
--

Price Chart

Open
36.00
High
37.00
Low
34.26
Close
35.68
Change
-1.50 (-4.11%)
Volume
29,720

Recent RNS announcements

24 Apr 202615:16:17Posting of Annual Report & Notice of AGM
13 Apr 202607:00:06Results for the year ended 31 December 2025
7 Apr 202607:01:00Notice of Results
7 Apr 202607:00:11Appointment of Nominated Adviser and Joint Broker
1 Apr 202607:00:08Block Listing Return

Annual Reports

1 Jul 2025Annual Report and Accounts (to 2024-12-31)
4 Jul 2024Annual Report and Accounts (to 2023-12-31)
11 Jul 2023Annual Report and Accounts (to 2022-12-31)

Directors (7)

JR
James Ronald OpenshawChief Financial Officer and Head of Corporate Development
5 mos
DS
Dr Steven John PowellNon-Executive Director
10 yrs 9 mos
SA
Stuart Arthur GallNon-Executive Director
2 yrs 2 mos
NR
Nick RodgersNon-Executive Director
2 yrs 2 mos
SM
Simon McKeatingSecretary
1 yrs 9 mos

In the Press

16 Feb 2026Cambridge Cognition shares jump on India deal newsYahoo Finance

Company details

Cambridge Cognition is a firm that specializes in creating digital health solutions to enhance our comprehension, identification, and management of brain health-related disorders.

Industry
Health Care
Sector
Health Care
LEI
213800SZKDIN122EPA96
Region
Europe
Admission date
18 Apr 2013
Website
www.cambridgecognition.com
X
@CANTABconnect

Shares details

Shares in issue
—
Last updated: 24 April 2026

Instrument details

ISIN
GB00B8DV9647
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Loading price data...
--
--

Price Chart

Open
36.00
High
37.00
Low
34.26
Close
35.68
Change
-1.50 (-4.11%)
Volume
29,720

Recent RNS announcements

24 Apr 202615:16:17Posting of Annual Report & Notice of AGM
13 Apr 202607:00:06Results for the year ended 31 December 2025
7 Apr 202607:01:00Notice of Results
7 Apr 202607:00:11Appointment of Nominated Adviser and Joint Broker
1 Apr 202607:00:08Block Listing Return

Annual Reports

1 Jul 2025Annual Report and Accounts (to 2024-12-31)
4 Jul 2024Annual Report and Accounts (to 2023-12-31)
11 Jul 2023Annual Report and Accounts (to 2022-12-31)

Directors (7)

JR
James Ronald OpenshawChief Financial Officer and Head of Corporate Development
5 mos
DS
Dr Steven John PowellNon-Executive Director
10 yrs 9 mos
SA
Stuart Arthur GallNon-Executive Director
2 yrs 2 mos
NR
Nick RodgersNon-Executive Director
2 yrs 2 mos
SM
Simon McKeatingSecretary
1 yrs 9 mos

In the Press

16 Feb 2026Cambridge Cognition shares jump on India deal newsYahoo Finance

Company details

Cambridge Cognition is a firm that specializes in creating digital health solutions to enhance our comprehension, identification, and management of brain health-related disorders.

Industry
Health Care
Sector
Health Care
LEI
213800SZKDIN122EPA96
Region
Europe
Admission date
18 Apr 2013
Website
www.cambridgecognition.com
X
@CANTABconnect

Shares details

Shares in issue
—
Last updated: 24 April 2026

Instrument details

ISIN
GB00B8DV9647
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Share Price35.68p
Day Change-1.50p(-4.11%)
24 Apr 15:17
Market closed
Share Price35.68p
Day Change-1.50p(-4.11%)
24 Apr 15:17
Market closed